Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Published on December 23, 2024

the Company’s ability to obtain or maintain the capital or grants necessary to fund its research and development activities, its ability to